The randomized placebo-phase design for clinical trials

Journal of Clinical Epidemiology

Volumn 54, Issue 6, 2001, Pages 550-557

  Feldman, Brian ^a   Wang, Elaine ^a   Willan, Andrew ^b   Szalai, John Paul ^c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Blinding; Clinical trials; Efficacy; Randomization; Statistics; Therapy

Indexed keywords

PLACEBO;

ARTHRITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; PHYSICIAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; SYSTEM ANALYSIS; TREATMENT OUTCOME; VALIDATION PROCESS;

HUMANS; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 0035014432     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(00)00357-7     Document Type: Article

References (29)

1. Gotay C.C. Accrual to cancer clinical trials. directions from the research literature Soc Sci Med. 33:1991;569-577.
2. Sackett D., Haynes R., Tugwell P. Clinical Epidemiology - A Basic Science for Clinical Medicine. 1985;Little, Brown, Boston, MA.
3. Feldman B.M., Giannini E.H. Where's the evidence? Putting clinical science into pediatric rheumatology. J Rheumatol. 23:1996;1502-1504.
4. Silverman E.D., Cawkwell G.D., Lovell D.J., Laxer R.M., Lehman T.J., Passo M.H., Zemel L.S., Giannini E.H. Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis. a randomized placebo controlled trial J Rheumatol. 21:1994;2353-2358.
5. J Rheumatol. 23:1996;1652-1656.
6. Schafer A. The ethics of the randomized clinical trial. N Engl J Med. 307:1982;719-724.
7. Kotwall C.A., Mahoney L.J., Myers R.E., DeCoste L. Reasons for non-entry in randomized clinical trials for breast cancer. a single institutional study J Surg Oncol. 50:1992;125-129.
8. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 317:1987;141-145.
9. Schulz K.F. Unbiased research and the human spirit. the challenges of randomized controlled trials Can Med Assoc J. 153:1995;783-786.
10. Klein M.C., Kaczorowski J., Robbins J.M., Gauthier R.J., Jorgensen S.H., Joshi A.K. Physicians' beliefs and behaviour during a randomized controlled trial of episiotomy. consequences for women in their care Can Med Assoc J. 153:1995;769-779.
11. Hills M., Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 8:1979;7-20.
12. Johannessen T., Fosstvedt D., Petersen H. Combined single subject trials. Scand J Primary Health Care. 9:1991;23-27.
13. Jaeschke R., Adachi J., Guyatt G., Keller J., Wong B. Clinical usefulness of amitriptyline in fibromyalgia. the results of 23 N-of-1 randomized controlled trials J Rheumatol. 18:1991;447-451.
14. Otani K., Nita I., Macaulay W., Georgescu H.I., Robbins P.D., Evans C.H. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol. 156:1996;3558-3562.
15. Bandara G., Mueller G.M., Galea-Lauri J., Tindal M.H., Georgescu H.I., Suchanek M.K., Hung G.L., Glorioso J.C., Robbins P.D., Evans C.H. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci. 90:1993;10,764-10,768.
16. Kavanaugh A.F., Davis L.S., Nichols L.A., Norris S.H., Rothlein R., Scharschmidt L.A., Lipsky P.E. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum. 37:1994;992-999.
17. Matteson E.L., Yocum D.E., St Clair E.W., Achkar A.A., Thakor M.S., Jacobs M.R., Hayes A.E., Heitman C.K., Johnston J.M. Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody Campath-1H administered by daily subcutaneous injection. Arthritis Rheum. 38:1995;1187-1193.
18. Hallstrom A.P., Verter J., Friedman L. Randomizing responders. Cardiac Arrhythmia Suppression Trial (CAST) investigators. Control Clin Trials. 12:1991;486-503.
19. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med. 324:1991;150-154.
20. Giannini E.H., Lovell D.J., Silverman E.D., Sundel R.P., Tague B.L., Ruperto N. Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis. a phase I/II study. Pediatric Rheumatology Collaborative Study Group J Rheumatol. 23:1996;919-924.
21. Lovell D.J., Giannini E.H., Reiff A., Cawkwell G.D., Silverman E.D., Nocton J.J., Stein L.D., Gedalia A., Ilowite N.T., Wallace C.A., Whitmore H., Finck B.K. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med. 342:2000;763-769.
22. Feldman B.M. Evaluation of a new single-arm randomized placebo phase design clinical trial using Monte Carlo computer simulation. 1995;University of Toronto, Toronto, Ontario. [MSc thesis].
23. Cox D. Regression models and life-tables. J Royal Stat Soc. Series(B 34):1972;187-220.
24. Giannini E.H., Brewer E.J., Kuzmina N., Shaikov A., Maximov A., Vorontsov I., Fink C.W., Newman A.J., Cassidy J.T., Zemel L.S. Methotrexate in resistant juvenile rheumatoid arthritis. results of the USA-USSR double-blind, placebo-controlled trial N Engl J Med. 326:1992;1043-1049.
25. Wolfe F., Hawley D.J., Cathey M.A. Measurement of gold treatment effect in clinical practice. evidence for effectiveness of intramuscular gold therapy J Rheumatol. 20:1993;797-801.
26. Lee E. Statistical methods for survival data analysis. 1980;Lifetime Learning, Belmont, CA.
27. Velleman P. Data desk Version 4.1. 1992;Data Description, Ithaca, NY.
28. Diggle P., Kenward M.G. Informative dropout in longitudinal data analyis. Appl Statist. 43:1994;49-93.
29. Dupont W.D., Plummer W.D. Power and sample size calculations. a review and computer program Control Clin Trials. 11:1990;116-128.